TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of$ 0.17. This compares to a loss of $0.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -464.71%. A quarter ago, it was expected that this company would post a loss of$ 0.22 per share when it actually produced a loss of $0.27, delivering a surprise of -22.73%.Over the last four quarters, the com ...